Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebral Protection with Head Cooling and Dexmedetomidine in Liver Transplant
NCT03102359Phase 2Unknown
- Sponsor
- Huazhong University of Science and Technology
- Start
- Apr 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dexmedetomidine in hepatic encephalopathy (HE) (4 arms), sponsored by Huazhong University of Science and Technology. Primary endpoint: Postoperative minimal hepatic encephalopathy at 14 days. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT03102359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03102359.